Assembly Biosciences's total assets for Q3 2024 were $100.26M, a decrease of -13.06% from the previous quarter. ASMB total liabilities were $74.26M for the fiscal quarter, a -7.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.